Casodex and Decreased appetite - a phase IV clinical study of FDA data

Summary:

Decreased appetite is reported as a side effect among people who take Casodex (bicalutamide), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Lupron, and have Metastases to bone.

The phase IV clinical study analyzes which people have Decreased appetite when taking Casodex. It is created by eHealthMe based on reports of 10,594 people who have side effects when taking Casodex from the FDA, and is updated regularly.

What is Casodex?

Casodex has active ingredients of bicalutamide. It is often used in prostate cancer. eHealthMe is studying from 10,725 Casodex users. Check the latest studies of Casodex.

What is Decreased appetite?

Decreased appetite is found to be associated with 4,029 drugs and 4,512 conditions by eHealthMe. Check the latest studies of Decreased appetite.

On Nov, 03, 2025

10,594 people reported to have side effects when taking Casodex.
Among them, 359 people (3.39%) have Decreased appetite.

Among these 359 people:

How long have people been on Casodex when they have Decreased appetite? *

What is the gender of people who have Decreased appetite when taking Casodex? *

female: 2.05 %
male: 97.95 %

What is the age of people who have Decreased appetite when taking Casodex? *

What are other drugs people take besides Casodex? *

What are other side effects people have besides Decreased appetite? *

Weight Decreased: 164 people, 45.68%
Weakness: 141 people, 39.28%
Fatigue (feeling of tiredness): 133 people, 37.05%
Nausea (feeling of having an urge to vomit): 114 people, 31.75%
Dizziness: 91 people, 25.35%
Anaemia (lack of blood): 85 people, 23.68%
Pain: 80 people, 22.28%
Constipation: 77 people, 21.45%
Prostatic Specific Antigen Increased: 77 people, 21.45%
Dyspnea (difficult or laboured breathing): 73 people, 20.33%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 42 people, 11.70%
Prostate Cancer Metastatic: 32 people, 8.91%
High Blood Pressure: 14 people, 3.90%
Neoplasm Malignant (cancer tumour): 10 people, 2.79%
Bone Density Decreased: 10 people, 2.79%
Pain: 10 people, 2.79%
Constipation: 9 people, 2.51%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 2.23%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 2.23%
Multiple Myeloma (cancer of the plasma cells): 7 people, 1.95%

* Approximation only. Some reports may have incomplete information.

Do you take Casodex and have Decreased appetite?

- Check whether Decreased appetite is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Casodex:

Casodex (10,725 reports)

Browse all side effects of Casodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Decreased appetite:

Browse all the drugs that are associated with Decreased appetite:

Decreased appetite (4,029 drugs)

Common conditions associated with Decreased appetite:

Diabetes - type 2: 12,123 reports
Blood pressure - high: 11,790 reports
Rheumatoid arthritis: 9,597 reports
Multiple myeloma: 8,131 reports
Pain exacerbated: 8,045 reports
Pain relief: 7,969 reports
Diabetes mellitus non-insulin-dependent: 7,684 reports
Depression: 6,752 reports
Antidepressant therapy: 6,751 reports
Hypernephroma: 6,469 reports

Browse all the conditions that are associated with Decreased appetite:

Decreased appetite (4,512 conditions)

Related publications that referenced our studies

Peng, C. C., Chen, C. Y., Chen, C. R., Chen, C. J., Shen, K. H., Chen, K. C., & Peng, R. Y., "Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model", Scientific reports, 2018 Jan .
Peng, C. C., Chen, C. Y., Chen, C. R., Chen, C. J., Shen, K. H., Chen, K. C., & Peng, R. Y., "Renal Damaging Effect Elicited by Bicalutamide Therapy Uncovered Multiple Action Mechanisms As Evidenced by the Cell Model", Scientific reports, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on bicalutamide (the active ingredients of Casodex) and Casodex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.